New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
International study validates less invasive approach to diagnosing mitochondrial disease

International study validates less invasive approach to diagnosing mitochondrial disease

International study validates less invasive approach to diagnosing mitochondrial diseaseParadigm for the diagnosis of Primary mitochondrial disorders. Credit: EMBO Molecular Medicine (2026). DOI: 10.1
Breakthroughs October 22,2026
International study validates less invasive approach to diagnosing mitochondrial disease

International study validates less invasive approach to diagnosing mitochondrial disease

International study validates less invasive approach to diagnosing mitochondrial diseaseParadigm for the diagnosis of Primary mitochondrial disorders. Credit: EMBO Molecular Medicine (2026). DOI: 10.1
Breakthroughs October 22,2026
International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseasesCredit: Unsplash/CC0 Public DomainAn international multidisciplinary group of 31 experts has updated
Allergy&Clinical immunology October 22,2026
International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseasesCredit: Unsplash/CC0 Public DomainAn international multidisciplinary group of 31 experts has updated
Allergy&Clinical immunology October 22,2026
Researchers call for investing in hospital nursing workforce to address health impacts of extreme heat

Researchers call for investing in hospital nursing workforce to address health impacts of extreme heat

Researchers call for investing in hospital nursing workforce to address health impacts of extreme heatCredit: Unsplash/CC0 Public DomainHospitals should make nurse staffing and supportive nurse work e
Public Health & Prevention October 22,2026
Researchers call for investing in hospital nursing workforce to address health impacts of extreme heat

Researchers call for investing in hospital nursing workforce to address health impacts of extreme heat

Researchers call for investing in hospital nursing workforce to address health impacts of extreme heatCredit: Unsplash/CC0 Public DomainHospitals should make nurse staffing and supportive nurse work e
Public Health & Prevention October 22,2026
Functional decline precedes cardiovascular disease events by many years

Functional decline precedes cardiovascular disease events by many years

Functional decline precedes cardiovascular disease events by many yearsby Lori SolomonFunctional decline begins many years before clinically apparent cardiovascular disease (CVD) events, according to
Cardiovascular Diseases October 21,2026
Functional decline precedes cardiovascular disease events by many years

Functional decline precedes cardiovascular disease events by many years

Functional decline precedes cardiovascular disease events by many yearsby Lori SolomonFunctional decline begins many years before clinically apparent cardiovascular disease (CVD) events, according to
Cardiovascular Diseases October 21,2026
Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapyCredit: Thirdman from PexelsThe Journal of Clinical Oncology has published secondary results from the
Hematology&Oncology October 21,2026
Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapyCredit: Thirdman from PexelsThe Journal of Clinical Oncology has published secondary results from the
Hematology&Oncology October 21,2026
Daily rhythms may matter for blood sugar management in type 2 diabetes

Daily rhythms may matter for blood sugar management in type 2 diabetes

Daily rhythms may matter for blood sugar management in type 2 diabetesCredit: Pixabay/CC0 Public DomainA research team led by Dr. Lee Da young, Dr. Nan Hee Kim of the Division of Endocrinology and Met
Diabetes & Endocrinology October 21,2026
Daily rhythms may matter for blood sugar management in type 2 diabetes

Daily rhythms may matter for blood sugar management in type 2 diabetes

Daily rhythms may matter for blood sugar management in type 2 diabetesCredit: Pixabay/CC0 Public DomainA research team led by Dr. Lee Da young, Dr. Nan Hee Kim of the Division of Endocrinology and Met
Diabetes & Endocrinology October 21,2026
PrEP pill can prevent HIV, but partner reactions might stand in the way

PrEP pill can prevent HIV, but partner reactions might stand in the way

PrEP pill can prevent HIV, but partner reactions might stand in the wayby Carol PetersCredit: Etatics Inc. from PexelsFear of accusations of infidelity, the stigma surrounding HIV and concerns about c
Infectious Diseases October 20,2026
PrEP pill can prevent HIV, but partner reactions might stand in the way

PrEP pill can prevent HIV, but partner reactions might stand in the way

PrEP pill can prevent HIV, but partner reactions might stand in the wayby Carol PetersCredit: Etatics Inc. from PexelsFear of accusations of infidelity, the stigma surrounding HIV and concerns about c
Infectious Diseases October 20,2026
Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of glandSingle cell sequencing and histopathology of zone-specific tissues collected from cancer-free
Family Medicine October 20,2026
Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of glandSingle cell sequencing and histopathology of zone-specific tissues collected from cancer-free
Family Medicine October 20,2026
How 'technoference' can disrupt parent‑child connections

How 'technoference' can disrupt parent‑child connections

How 'technoference' can disrupt parent‑child connectionsby Gizem Keskin, Penny Pexman, Sheri MadiganIt's best for children's learning and development when adults respond quickly to the
Pediatrics October 20,2026
How 'technoference' can disrupt parent‑child connections

How 'technoference' can disrupt parent‑child connections

How 'technoference' can disrupt parent‑child connectionsby Gizem Keskin, Penny Pexman, Sheri MadiganIt's best for children's learning and development when adults respond quickly to the
Pediatrics October 20,2026
Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinomaCredit: Pixabay/CC0 Public DomainInitial results of the NRG Oncology NRG-GI003 c
Hematology&Oncology October 19,2026
Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinomaCredit: Pixabay/CC0 Public DomainInitial results of the NRG Oncology NRG-GI003 c
Hematology&Oncology October 19,2026
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com